- Details
- Press Release
Sabinsa’s Curcumin C3 Complex® in combination with BioPerine® (CBP) has an inhibitory effect on malignant mesothelioma cells, according to an in vitro and in vivo study published in Journal of Experimental and Clinical Cancer Research.
- Details
- Press Release
Sabinsa continues its global expansion with the opening of a warehousing, sales and distribution office in Poland and bringing on staff to serve customers in the growing East European, Eastern Block as well as CIS countries.
- Details
- Press Release
Sabinsa’s four Sami Labs manufacturing sites in India were recently audited by the licensed Certification Body, Bureau Veritas Certification Holding SAS – UK branch, and achieved Foundation Food Safety System Certification 22000 (FSSC 22000). FSSC 22000 replaces the previous ISO 22000: 2005 - FSMS (Food Safety Management System) achieved by these Sami facilities till 2018.
- Details
- Press Release
Sabinsa’s Curcumin C3 Complex® has been studied as an adjuvant therapy with several cancer drugs in the past, and the body of science continues to grow with the recent publication of more positive research.
- Details
- Press Release
Patented Turmeric Extract Deemed Safe for Use in Foods and Beverages
After a comprehensive review of safety and toxicology data by an independent panel of scientists of international repute convened by Soni & Associates Inc., Sabinsa’s patented color-free Curcumin C3 Reduct® tetrahydrocurcuminoids, a metabolite of curcumin, has been found to meet criteria as Generally Recognized As Safe (GRAS) as per FDA’s scientific procedures.